Pharma firm Almac backs clinical trials for coronavirus treatment and vaccines
Belfast Telegraph
Northern Ireland multinational pharmaceutical firm Almac is a partner in 11 clinical research trials across the world in the search for an effective Covid-19 vaccine.
The pharma giant, which employs more than 5,000 people in its operations across Europe, Asia and the USA, said it has begun work on supporting 11 separate crucial research projects into Covid-19 treatment options for a variety of global pharmaceutical, biotech and research institutions.